Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | KIF11 | P52732 | 2/20 | 0.50 |
| ▸ | CASP3 | P42574 | 2/20 | 0.44 |
| ▸ | KDM1A | O60341 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CCR1 | P32246 | 1/20 | 0.40 |
| ▸ | CCR5 | P51681 | 1/20 | 0.40 |
| ▸ | CCR8 | P51685 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29595709 | 1.00 | NPSR1 (0.53) | NPSR1KDM4EKMT2AKIF11CASP3 | |
| SCHEMBL25012750 | 0.89 | NPSR1 (0.46) | NPSR1KDM4EKMT2AKIF11CASP3 | |
| SCHEMBL27344645 | 0.88 | KIF11 (0.63) | NPSR1KDM4EKMT2AKIF11CASP3 | |
| SCHEMBL24689583 | 0.87 | CCR1 (0.64) | NPSR1KDM4EKMT2AKIF11CASP3 | |
| SCHEMBL13830687 | 0.86 | NPSR1 (0.50) | NPSR1KDM4EKMT2AKIF11CASP3 | |
| SCHEMBL28530523 | 0.86 | KIF11 (0.61) | NPSR1KDM4EKMT2AKIF11KDM1A | |
| SCHEMBL29690424 | 0.86 | KIF11 (0.61) | NPSR1KDM4EKMT2AKIF11KDM1A | |
| SCHEMBL4342508 | 0.84 | KIF11 (0.59) | NPSR1KDM4EKMT2AKIF11KDM1A | |
| SCHEMBL30238069 | 0.84 | NPSR1 (0.43) | NPSR1KDM4EKMT2AKIF11CASP3 | |
| SCHEMBL3180184 | 0.83 | CYP11B1 (0.55) | NPSR1KDM4EKMT2AKIF11KDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025132825-A1 | 1H-IMIDAZO[4,5-C]QUINOLINE METAL-BASED COMPLEXES USEFUL AS MEDICAMENTS | FUNDACIÓN DONOSTIA INTERNATIONAL PHYSICS CENTER - DIPC (ES) | 2025-06-26 | — | — | WO | claimed |
| US-20220259240-A1 | PROCESS FOR THE PREPARATION OF RUTHENIUM COMPLEXES | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2022-08-18 | — | — | US | claimed |
| EP-4013764-A1 | PROCESS FOR THE PREPARATION OF RUTHENIUM COMPLEXES | Johnson Matthey Public Limited Company (GB) | 2022-06-22 | — | — | EP | claimed |
| WO-2021032952-A1 | PROCESS FOR THE PREPARATION OF RUTHENIUM COMPLEXES | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2021-02-25 | — | — | WO | claimed |
| US-20050233233-A1 | Luminescent lanthanide complexes with imine ligands and devices made with such complexes | RADU NORA S | 2005-10-20 | — | — | US | claimed |
| EP-1406909-A1 | LUMINESCENT LANTHANIDE COMPLEXES WITH IMINE LIGANDS AND DEVICES MADE WITH SUCH COMPLEXES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2004-04-14 | — | — | EP | claimed |
| US-20030129450-A1 | Luminescent lanthanide complexes with imine ligands and devices made with such complexes | LG CHEM, LTD. (KR) | 2003-07-10 | — | — | US | claimed |
| WO-2003008424-A1 | LUMINESCENT LANTHANIDE COMPLEXES WITH IMINE LIGANDS AND DEVICES MADE WITH SUCH COMPLEXES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-01-30 | — | — | WO | claimed |
| US-20260028351-A1 | KCC2 POTENTIATORS AND USES THEREOF | AXONIS THERAPEUTICS, INC. | 2026-01-29 | — | — | US | disclosed |
| WO-2025132825-A1 | 1H-IMIDAZO[4,5-C]QUINOLINE METAL-BASED COMPLEXES USEFUL AS MEDICAMENTS | FUNDACIÓN DONOSTIA INTERNATIONAL PHYSICS CENTER - DIPC (ES) | 2025-06-26 | — | — | WO | disclosed |
| US-20250074925-A1 | RARE EARTH COMPLEX | SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) | 2025-03-06 | — | — | US | disclosed |
| EP-4365180-A1 | RARE EARTH COMPLEX | Tosoh Corporation (JP) | 2024-05-08 | — | — | EP | disclosed |
| US-11935803-B2 | Resin composition, laminate, semiconductor wafer with resin composition layer, substrate for mounting semiconductor with resin composition layer and semiconductor device | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2024-03-19 | — | — | US | disclosed |
| US-20240002927-A1 | METHODS FOR DETECTION OF NUCLEOTIDE MODIFICATION | BLUECAT IP LIMITED (GB) | 2024-01-04 | — | — | US | disclosed |
| EP-1214596-A1 | GLUCOSE SENSING MOLECULES HAVING SELECTED FLUORESCENT PROPERTIES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2002-06-19 | — | — | EP | disclosed |
| US-20020043651-A1 | Fluorescent lifetime assays for non-invasive quantification of analytes such as glucose | ENERGY, U.S. DEPARTMENT OF | 2002-04-18 | — | — | US | disclosed |
| US-20020010279-A1 | Saccharide sensing molecules having enhanced fluorescent properties | LAWRENCE LIVERMORE NATIONAL SECURITY LLC | 2002-01-24 | — | — | US | disclosed |
| WO-2001075450-A2 | FLUORESCENT LIFETIME ASSAYS FOR NON-INVASIVE QUANTIFICATION OF ANALYTES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2001-10-11 | — | — | WO | disclosed |
| WO-2001074968-A2 | SACCHARIDE SENSING MOLECULES HAVING ENHANCED FLUORESCENT PROPERTIES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2001-10-11 | — | — | WO | disclosed |
| WO-2001020334-A1 | GLUCOSE SENSING MOLECULES HAVING SELECTED FLUORESCENT PROPERTIES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2001-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050233233-A1 | Luminescent lanthanide complexes with imine ligands and devices made with such complexes | SSB, LARP7, LIG3 | NPSR1 2134/4885KDM4E 2479/4885KMT2A 3459/4885 |
| US-20260028351-A1 | KCC2 POTENTIATORS AND USES THEREOF | GRIN2C, HCN1, KCNC1 | NPSR1 503/4885KDM4E 3650/4885KMT2A 2979/4885 |
| US-20020010279-A1 | Saccharide sensing molecules having enhanced fluorescent properties | SLC2A1, SLC2A9, SLC2A2 | NPSR1 2303/4885KDM4E 3240/4885KMT2A 4458/4885 |
| US-20220259240-A1 | PROCESS FOR THE PREPARATION OF RUTHENIUM COMPLEXES | RUVBL1, RUVBL2, RPP30 | NPSR1 2631/4885KDM4E 2618/4885KMT2A 4330/4885 |
| US-20250074925-A1 | RARE EARTH COMPLEX | L1CAM, CHRM1, NPM1 | NPSR1 720/4885KDM4E 4590/4885KMT2A 3223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.